Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2001-10-24
pubmed:abstractText
Reactive intermediates generated by phagocytic white blood cells are of central importance in destroying microorganisms, but they may also damage normal tissue at sites of inflammation. To investigate the potential role of such oxidants in tissue injury, we used gas chromatography/mass spectrometry to quantify levels of o,o'-dityrosine in mouse peritoneal neutrophils and urine. In wild-type animals, neutrophils markedly increased their content of protein-bound dityrosine when they were activated in vivo. This increase failed to occur in mice that were deficient in the phagocyte NADPH oxidase. Levels of o,o'-dityrosine in urine mirrored those in neutrophil proteins. When o,o'-[(14)C]dityrosine was injected intravenously into mice, the radiolabel was not metabolized or incorporated into tissue proteins: instead, it was recovered in urine with near-quantitative yield. Patients with sepsis markedly increased their output of o,o'-dityrosine into urine, suggesting that systemic inflammation also may be a potent source of oxidative stress in humans. These observations demonstrate that activated neutrophils produce o,o'-dityrosine cross-links in tissue proteins, which may subsequently be degraded into free amino acids and excreted into urine. Our results indicate that mouse phagocytes use oxidants produced by the NADPH oxidase to create o,o'-dityrosine cross-links in vivo and raise the possibility that reactive intermediates produced by this pathway promote inflammatory tissue damage in humans.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0003-9861
pubmed:author
pubmed:copyrightInfo
Copyright 2001 Academic Press.
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
395
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
69-77
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11673867-Acute Disease, pubmed-meshheading:11673867-Aged, pubmed-meshheading:11673867-Aged, 80 and over, pubmed-meshheading:11673867-Animals, pubmed-meshheading:11673867-Biological Markers, pubmed-meshheading:11673867-Carbon Radioisotopes, pubmed-meshheading:11673867-Chromatography, High Pressure Liquid, pubmed-meshheading:11673867-Female, pubmed-meshheading:11673867-Humans, pubmed-meshheading:11673867-Inflammation, pubmed-meshheading:11673867-Injections, Intravenous, pubmed-meshheading:11673867-Male, pubmed-meshheading:11673867-Mice, pubmed-meshheading:11673867-Mice, Inbred C57BL, pubmed-meshheading:11673867-Mice, Mutant Strains, pubmed-meshheading:11673867-Middle Aged, pubmed-meshheading:11673867-NADPH Oxidase, pubmed-meshheading:11673867-Neutrophils, pubmed-meshheading:11673867-Oxidative Stress, pubmed-meshheading:11673867-Proteins, pubmed-meshheading:11673867-Sepsis, pubmed-meshheading:11673867-Spectrometry, Mass, Electrospray Ionization, pubmed-meshheading:11673867-Tyrosine, pubmed-meshheading:11673867-Urine
pubmed:year
2001
pubmed:articleTitle
NADPH oxidase of neutrophils elevates o,o'-dityrosine cross-links in proteins and urine during inflammation.
pubmed:affiliation
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Controlled Clinical Trial, Research Support, Non-U.S. Gov't